Archives

  • 2026-10
  • 2026-09
  • 2026-08
  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-07
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • Meropenem Trihydrate: Broad-Spectrum Carbapenem Antibioti...

    2026-02-27

    Meropenem Trihydrate: Broad-Spectrum Carbapenem Antibiotic Benchmarks

    Executive Summary: Meropenem trihydrate exhibits potent, broad-spectrum antibacterial activity against gram-negative, gram-positive, and anaerobic pathogens, with MIC90 values among the lowest for clinically relevant isolates (APExBIO). Its mechanism involves irreversible inhibition of bacterial cell wall synthesis via high-affinity binding to penicillin-binding proteins (PBPs) (Dixon et al., 2025). The compound is water-soluble (≥20.7 mg/mL, gentle warming), stable at -20°C, and recommended for short-term solution use only. Metabolomics studies reveal that resistance to carbapenems in Enterobacterales is primarily mediated by carbapenemase production, with distinct metabolic signatures detectable by LC-MS/MS (Dixon et al., 2025). Meropenem trihydrate is for research use only and must not be used for diagnostic or therapeutic purposes.

    Biological Rationale

    Carbapenems, such as meropenem trihydrate, are frontline agents used to address multidrug-resistant bacterial infections (Dixon et al., 2025). Their broad-spectrum action covers a gamut of gram-negative and gram-positive bacteria, including Escherichia coli, Klebsiella pneumoniae, Enterobacter spp., and Streptococcus pneumoniae (APExBIO). The increasing emergence of carbapenem-resistant Enterobacterales (CRE) poses a significant global health challenge, making both mechanism-of-action research and resistance biomarker discovery urgent priorities. Metabolomic profiling has identified distinct chemical signatures associated with carbapenemase-producing phenotypes, offering new avenues for diagnostics and targeted therapy (Dixon et al., 2025).

    Mechanism of Action of Meropenem Trihydrate

    Meropenem trihydrate is a β-lactam antibiotic of the carbapenem subclass. It acts by covalently binding to penicillin-binding proteins (PBPs), primarily PBP2 and PBP3, which are critical for bacterial cell wall peptidoglycan crosslinking (Dixon et al., 2025). This binding inhibits transpeptidase activity, disrupting cell wall synthesis, triggering cell lysis, and resulting in rapid bactericidal effects. Meropenem is stable against most β-lactamases, including many extended-spectrum β-lactamases, but is susceptible to hydrolysis by carbapenemases. Its antibacterial activity is pH-dependent, with optimal efficacy at physiological pH 7.5 and reduced activity at acidic pH 5.5 (APExBIO).

    Evidence & Benchmarks

    • Meropenem trihydrate demonstrates MIC90 values ≤0.25 mg/L for E. coli and K. pneumoniae clinical isolates at pH 7.5 (APExBIO).
    • Carbapenem resistance in Enterobacterales is predominantly mediated by carbapenemase enzyme production, as confirmed by LC-MS/MS metabolomics profiling (Dixon et al., 2025).
    • Metabolomic biomarkers (n=21) enable discrimination between carbapenemase-producing and non-producing isolates with AUROC ≥ 0.845 in under 7 hours (Dixon et al., 2025).
    • In vivo, meropenem trihydrate reduces hemorrhage, fat necrosis, and pancreatic infection in acute necrotizing pancreatitis rat models, with potential enhancement by deferoxamine (APExBIO).
    • Meropenem trihydrate is highly soluble in water (≥20.7 mg/mL, gentle warming) and DMSO (≥49.2 mg/mL), but insoluble in ethanol (APExBIO).
    • For optimal stability, storage at -20°C is required; aqueous solutions should be used immediately and not stored for extended periods (APExBIO).

    This article extends evidence from 'Meropenem Trihydrate (SKU B1217): Scenario-Driven Solutions' by providing updated metabolomics-driven resistance benchmarks, clarifies mechanistic findings discussed in 'Meropenem Trihydrate in Translational Research' by highlighting new LC-MS/MS biomarker data, and updates solubility and workflow integration compared to 'Meropenem Trihydrate: Broad-Spectrum Carbapenem Antibiotic'.

    Applications, Limits & Misconceptions

    Meropenem trihydrate is widely used in research on gram-negative and gram-positive bacterial infections, antibiotic resistance mechanisms, and as a standard in susceptibility testing. Its high β-lactamase stability and clear mechanism make it a model compound for resistance studies (Dixon et al., 2025). In translational research, it supports the discovery of resistance biomarkers and the evaluation of antibacterial regimens in animal models (see translational research article).

    Common Pitfalls or Misconceptions

    • Meropenem trihydrate is not suitable for clinical or diagnostic use; it is strictly for research applications (APExBIO).
    • It is ineffective against bacteria producing potent carbapenemases (e.g., KPC, NDM, OXA-48), despite its broad-spectrum classification (Dixon et al., 2025).
    • Stability issues arise if solutions are stored at room temperature or used beyond recommended time frames; always prepare fresh aliquots (APExBIO).
    • Solubility in ethanol is negligible; use only water or DMSO for stock preparations (APExBIO).
    • pH-dependent activity is often overlooked; acidic pH reduces efficacy (APExBIO).

    Workflow Integration & Parameters

    For experimental reproducibility, dissolve meropenem trihydrate in sterile water (≥20.7 mg/mL) or DMSO (≥49.2 mg/mL) with gentle warming. Avoid ethanol. Prepare working solutions immediately before use. Recommended storage is at -20°C, protected from moisture. For susceptibility assays, use physiological pH (7.4–7.5) buffers to maximize activity. Meropenem trihydrate is compatible with cell-based assays, animal infection models, and LC-MS/MS workflows for resistance phenotyping (see scenario-driven lab guide; evidence-based workflow article).

    Conclusion & Outlook

    Meropenem trihydrate, as supplied by APExBIO (SKU B1217), remains a key molecule in antibacterial research, offering robust, reproducible activity across a spectrum of pathogens. Recent advances in metabolomics and resistance biomarker discovery—validated by LC-MS/MS—enhance its value for translational microbiology and systems biology (Dixon et al., 2025). Continued vigilance is needed for emerging resistance mechanisms, and rigorous adherence to storage, solubility, and assay parameters is essential for optimal results. For further reference and product details, see the Meropenem trihydrate product page.